Health News

• Educationist and activist Sonam Wangchuk has been hospitalized and is currently reported as "weak but stable" by Safdarjung Hospital. • The hospitalization follows a Delhi High Court order requiring daily health checks for Wangchuk due to his deteriorating physical condition. • Wangchuk has transitioned from a grassroots innovator to a national figure leading political and environmental movements in Ladakh, as well as Gen Z education reforms.

• The Pharmaceutical Journal reported on several key healthcare developments, including progress toward a single national formulary and the potential introduction of a pharmacy performers list. • The publication highlighted a "stark lack of government response" regarding the valproate redress scheme, signaling ongoing frustration over compensation for affected individuals. • Efforts are underway to establish closer regulatory ties between the UK, India, and the United States to streamline pharmaceutical oversight.

• Researchers have published a new study in Science Translational Medicine detailing how the Epstein-Barr virus triggers immune responses that cause inflammation and nervous system damage in multiple sclerosis patients. • Separately, clinical trials have demonstrated the effectiveness of a treatment that inhibits the PCSK9 protein to significantly lower dangerous LDL cholesterol levels. • This cholesterol treatment can reduce LDL levels to 50 or 60, whereas adults not using medication typically maintain levels above 100.

• AI Prognosis reports on a whistleblower at Mayo Clinic and Sutter Health's legal response to a lawsuit regarding the use of the Abridge AI scribe. • The roundup examines critical industry debates surrounding informed consent for AI tools and the impact of artificial intelligence on overall healthcare costs. • Additional coverage includes a competition focused on AI-driven drug modeling to accelerate pharmaceutical development.

• The WHO Europe chief has warned that AI tools are being rapidly deployed in healthcare across 53 member countries without sufficient oversight. • Data reveals a stark imbalance: while two-thirds of these nations use AI for diagnostics and half use AI chatbots, only 8% (one in twelve) have a health-specific AI strategy. • This lack of governance risks causing biased diagnoses and eroding public trust in healthcare systems.

• Researchers have identified new threats of flesh-eating bacteria in summer waters, coinciding with a broader decline in public health oversight. • Dr. Jha warns that the Trump administration is dismantling critical policies and incentives intended to combat the nationwide chronic disease epidemic. • The U.S. withdrawal from the World Health Organization and the dismantling of USAID have weakened global health coordination, specifically impacting the Ebola response in the Democratic Republic of Congo.

• The FDA has approved the use of Paxlovid for children aged 12 and older who weigh at least 88 pounds. • AstraZeneca reported that its heart disease drug failed a pivotal trial, marking a significant setback in the company's cardiovascular development goals. • Eli Lilly launched a new website to advocate that obesity is a chronic, complex disease rather than just a risk factor for other medical complications.

• Poison control center calls involving semaglutide drugs, including Ozempic and Wegovy, have surged following their approval for weight management. • Researchers indicate that the spike in reports is primarily linked to accidental dosing errors rather than intentional misuse. • This trend highlights a critical safety concern regarding the administration of high-demand weight loss medications.

• SPARK has completed internal validation across more than 1,000 clinical MRI cases involving prostate cancer, Alzheimer’s, Parkinson’s, and Traumatic Brain Injury (TBI). • The study demonstrated consistent signal relationships that correlate with known disease states, suggesting the technology's effectiveness in identifying these conditions. • This milestone is critical for proving the reliability of SPARK's diagnostic capabilities across multiple complex neurological and oncological pathologies.

• Stanford Medicine specialists have issued a warning regarding the rising use of cannabis among adults over 65, noting that modern marijuana is significantly more potent than in the past. • The experts highlighted five specific risks associated with cannabis use in older populations, suggesting that the potential dangers may currently be underestimated. • This guidance is critical as aging populations increasingly turn to cannabis for health reasons, potentially facing unforeseen complications due to increased potency.

• The WHO announced the first patient has entered a randomized platform trial in the Democratic Republic of the Congo to test the monoclonal antibody MBP134 and remdesivir against the Bundibugyo virus. • This clinical trial aims to determine if these antiviral therapies, used alone or in combination, can improve survival rates as Ebola-related cases and deaths continue to rise. • Separately, rising health affordability crises and medical system frustrations are driving increased public and political demand for government intervention regarding drug prices and insurance premiums.

• Between June 27 and July 4, 2026, the FDA issued two major approvals: expanding Casgevy gene therapy for sickle cell disease patients aged 2 and older, and approving Tregzi, the first Treg cell immunotherapy for chronic graft-versus-host disease. • The roundup also tracks critical healthcare developments across the US, UK, Canada, Australia, and the EU, including NHS funding updates, EMA regulatory decisions, and various biotech deals. • These updates are significant for clinicians, biotech investors, and policy watchers as they signal advancements in gene therapy and hospital consolidation trends.

• The U.S. Food and Drug Administration (FDA) is investigating reports of neurological complications in patients of Venezuelan ancestry following the administration of anesthesia. • The probe focuses on identifying a potential link between specific anesthetic agents and adverse neurological reactions unique to this demographic. • This investigation is critical for patient safety, as it may uncover genetic predispositions or drug interactions that necessitate changes to anesthesia protocols.

• Healthtech experts are debating whether general-purpose Large Language Models (LLMs) are now outperforming specialized clinical AI tools like OpenEvidence. • The discussion covers significant industry developments, including Midjourney's exploration of MRI imaging and UnitedHealth Group's (UNH) strategic push into AI. • Abridge's partnership and "bet" on NVIDIA are highlighted as a key driver for the next generation of medical documentation and AI integration.

• Emerging public health risks, including the spread of screwworm and flesh-eating bacteria, are increasing following deep budget cuts to federal health agencies under the Trump administration. • These funding reductions have targeted specific health programs, potentially limiting the ability of agencies to track and contain dangerous pathogens. • Federal officials have denied that these cuts put the public at risk, asserting that the CDC maintains visibility into disease trends through alternative national surveillance systems.

• Bindu Shajan Perappadan reports on several Indian healthcare reforms, including the expansion of QR code-based traceability to vaccines, antimicrobials, and cancer medicines to improve drug security. • The government is introducing measures to simplify drug import procedures for testing, enhancing CGHS financial powers for faster cashless treatment, and launching the PM Family Care Tracker for maternal and child health. • Additional initiatives focus on expanding the fight against anaemia and providing affordable digital health management systems tailored for small clinics.

• Opinion writers for KFF Health News address critical public health concerns, including the loss of the United States' measles-eliminated status and the safety of sunscreen. • One contributor argues that the U.S. can no longer claim to have eliminated measles due to recent outbreaks and declining vaccination rates. • The collection also features a political perspective questioning the security of the pharmaceutical supply chain and the influence of Chinese Communist Party-controlled companies on prescription refills.

• Radio 2 and 1Xtra presenter Trevor Nelson is taking a temporary break from his broadcasting duties to focus on recovering from health issues. • The announcement was made on Friday afternoon by colleague Richie Anderson, who is currently covering Nelson's shows and offering public support. • This health hiatus follows a recent celebration of Nelson's professional achievements at the Television and Radio Industries Club (Tric) Awards earlier in the week.

• Amazon has announced a massive $13 billion investment in India, specifically targeting the expansion of its artificial intelligence and cloud computing infrastructure. • Several other startups have successfully secured fresh capital, including healthtech and beauty-focused companies SuperLiving, Bodycraft, and Zave. • These developments highlight a significant surge in funding for AI and specialized consumer services, signaling strong investor confidence in the Indian tech ecosystem.

• White House deputy assistant for domestic policy Heidi Overton is reportedly among the final candidates being considered to lead the Food and Drug Administration (FDA). • Overton is a medical doctor who holds a doctorate in clinical investigation from Johns Hopkins University, bringing significant medical and policy expertise to the role. • This potential appointment is critical as the FDA head oversees the safety and efficacy of pharmaceuticals and food products across the United States.

• The FDA has granted a new indication for the drug Tzield, expanding its use to patients who have already progressed to Stage 3 type 1 diabetes. • This latest approval aims to preserve residual beta cell function, building on previous expansions in April 2026 that extended the drug's use to children as young as one year old. • The decision was based on the PROTECT trial, which demonstrated a statistically significant effect on C-peptide, a surrogate endpoint used to predict clinical benefit.

• The FDA approved a third over-the-counter version of naloxone nasal spray on Tuesday, June 16, to increase accessibility and reduce costs for overdose reversal. • Separately, a reported disruption in breast biopsy services is expected to impact patient care and may necessitate adjustments to clinical management. • These developments highlight critical shifts in public health accessibility and the operational challenges facing diagnostic medical services.

• Philips CEO Roy Jakobs appeared on ‘Varney & Co.’ to discuss how AI integration is improving patient care and mitigating critical staffing shortages for clinicians. • Regulators issued a recall for nearly 13,000 toddler tower stools across three different brands following reports of collapsing and tipping that caused dozens of injuries. • Trulieve CEO Kim Rivers detailed the implications of the Trump administration's decision to reclassify state-licensed medical cannabis from Schedule 1 to Schedule 3.

• Indian startups across deeptech, space, AI, healthtech, and consumer brands experienced a surge in funding and strategic partnerships. • Bengaluru-based Biodimension secured ₹8 crore in a funding round led by the IAN Angel Fund to advance healthcare and life sciences. • New developments in the space sector aim to strengthen India's launch vehicle ecosystem and reduce strategic reliance on imported propulsion technologies.

• The Vanderbilt Report's weekly briefing for June 1–8, 2026, highlights several major medical breakthroughs, including new findings regarding GLP-1 weight-loss drugs. • Key developments include the discovery of a "striking new cancer signal" associated with GLP-1 medications and the emergence of a one-shot gene editing infusion. • These advancements are significant as they potentially expand the therapeutic use of weight-loss drugs and simplify the delivery of genetic treatments.

• The Pharmaceutical Journal has released a detailed analysis of the new community pharmacy contract. • The report examines whether the new framework will stabilize medicines funding and evaluates its promises regarding long-term systemic reform. • A key focus is placed on how new national prescribing services will integrate with existing local commissioning structures.

• An Ebola outbreak in the Democratic Republic of Congo has sickened over 1,000 people and resulted in nearly 250 deaths. • A new study clarifies that while parental depression is strongly linked to child neurodevelopmental disorders such as autism, the use of antidepressant medications is not a cause. • These findings directly challenge claims made by RFK Jr. regarding the impact of antidepressants on child development.

• In the phase III INDIGO trial, the investigational monoclonal antibody obexelimab substantially outperformed a placebo in treating immunoglobulin (Ig)G4-related disease. • This development positions obexelimab to compete with the only drug currently approved for the condition, potentially offering patients a new therapeutic option. • Separately, the CDC and state partners published a report in Morbidity and Mortality Weekly Report urging clinicians to increase screening for brucellosis.